AF
ORIC icon

Allworth Financial’s Oric Pharmaceuticals ORIC Stock Holding History

Allworth Financial’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02K Buy
279
+139
+99% +$1.26K ﹤0.01% 4347
2026
Q1 		$1.77K Buy
+140
New +$1.59K ﹤0.01% 4381
2025
Q4 		– Sell
-2
Closed -$24 – 5212
2025
Q3 		$24 Hold
2
– – ﹤0.01% 4810
2025
Q2 		$21 Buy
+2
New +$13 ﹤0.01% 4516

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Allworth Financial's ORIC Position: Q2 2026 in Review

Allworth Financial increased its Oric Pharmaceuticals (ORIC) stake by 99% in Q2 2026, buying an estimated $1.26K and bringing the position to 279 shares worth $3.02K. The position accounts for ﹤0.01% of the portfolio, ranked #4347.

Allworth Financial first reported a position in ORIC in Q2 2025 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Allworth Financial held 279 shares of Oric Pharmaceuticals worth $3.02K as of Q2 2026.
  • Allworth Financial bought 139 Oric Pharmaceuticals shares in Q2 2026, an estimated $1.26K.
  • Oric Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4347 holding.
  • Allworth Financial first reported a position in Oric Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.